|
Possible side effects
|
267 (74.8)
|
251 (82.0)
|
518 (78.1)
|
|
Lack of comprehensive field evaluation before marketing
|
266 (74.5)
|
241 (78.8)
|
507 (76.5)
|
|
Implementation in our country before wide implementation in other countries
|
199 (55.9)
|
184 (60.1)
|
383 (57.9)
|
|
Vaccines which will be administered here are different than the vaccines in the US
|
153 (42.9)
|
137 (44.9)
|
290 (43.8)
|
|
Do not have trust in the effectiveness of the vaccine
|
157 (44.0)
|
114 (37.3)
|
271 (40.9)
|
|
Do not trust Ministry of Health's practices
|
147 (41.2)
|
104 (34.0)
|
251 (37.9)
|
|
Due to the risk of acquiring H1N1 following vaccination
|
71 (19.9)
|
66 (21.6)
|
137 (20.7)
|
|
The disease is mild
|
59 (16.5)
|
34 (11.1)
|
93 (14.0)
|
|
Contracting the disease is safer
|
34 (9.5)
|
13 (4.2)
|
47 (7.1)
|
|
Other
|
30 (8.4)
|
15 (4.9)
|
45 (6.8)
|
